Trials / Completed
CompletedNCT07027215
Augmented Sensory in Cancer-Related Neuropathic Patients"
Impact of Augmented Sensory Feedback on Motor Control and Risk of Falling in Cancer-Related Neuropathic Patients"
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Isra University, Jordan · Academic / Other
- Sex
- Female
- Age
- 35 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
this research studied the effect of augmented sensory feedback program on motor control and risk of falling in patient with CIPN.
Detailed description
Design: A randomized control trial was conducted to investigate the impact of augmented sensory feedback paradigm on motor control and risk of falling in patient with Chemotherapy-induced peripheral neuropathy. Data were collected pre and post treatment from out-patient clinic of the Faculty of Medicine and Faculty of Physical Therapy South Valley University, between January 2023and March 2024. The study was approved by the ethical committee of the Faculty of Physical Therapy, South Vally University, Egypt. The study protocol was explained in detail to every patient and signed written consent was obtained before participation. Participants: forty female patients with CIPN were recruited from out-patient clinic of the Faculty of Medicine and Faculty of Physical Therapy South Valley University, between January 2023and March 2024.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Gradual Intermittent pneumatic compression therapy (IPC),Balance excercises.PNF technique | PNF technique |
| COMBINATION_PRODUCT | selected physical therapy program as arm excercises | selected physical therapy program only. The program consisted of (core exercises, AROM exercises, and stretching exercises for LL for 18 sessions every other day, over 6 weeks |
Timeline
- Start date
- 2024-01-20
- Primary completion
- 2024-03-25
- Completion
- 2024-05-30
- First posted
- 2025-06-18
- Last updated
- 2025-12-22
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07027215. Inclusion in this directory is not an endorsement.